Like many Americans, I’ve spent the week both fascinated and horrified by the scandal surrounding David Petraeus and his biographer, Paula Broadwell. Why? I want to ask. Why would two driven, accomplished people, whose successes in life have no doubt … Read more

There are two generally prevailing ideas about the thorny relationship between pharmaceutical companies and diabetes research. # 1: Pharmaceutical companies don’t want to cure diabetes because a cure would cost them billions in yearly revenue. # 2: Pharmaceutical companies are … Read more

New York Times columnist Mark Bittman has added a touch of controversy to the morning with his article, “Is Alzheimer’s Type 3 Diabetes?” A friend of mine forwarded it to me at the precise moment when I was doing yet another … Read more

Anyone else catch the story yesterday about how children with Type 1 diabetes are living longer than previous generations of kids with the disease? According to a study published on July 30 in Diabetes (and summarized here),  there’s been about a 15-year … Read more

I just got a response to my previous post about the ADA Scientific Sessions  that I thought would be worth reposting here and responding to, since I know it’s an issue that lurks beneath the surface in many conversations about pharmaceutical … Read more

I’m at the 2012 ADA Scientific Sessions and am keeping a live blog about my experiences (here’s a link to my day 1 coverage of the ADA scientific sessions). I’m also tweeting about from at catherine_price, at hashtag #ADA2012.  Included … Read more

Today marks the start of the 2012 American Diabetes Association (ADA) Scientific Sessions, being held this year in Philadelphia. I’ll be heading over there later today to check out what’s going on and live-blogging my experience (and sending Twitter updates … Read more

Last week when I went to the diabetes clinic expecting to be scolded for my numbers, the nutritionist told me jokingly that they only beat patients with an A1c of over 8%.  The idea of punishing people for their blood … Read more

Yesterday I took part in a tweetchat with Dr. Richard Bessar of ABC News. Joining the chat were representatives from the Centers for Disease Control, as well as many from major diabetes centers. The topic was whether type 2 is … Read more

The U.S. Food and Drug Administration (FDA) will meet later this month to discuss making popular prescription drugs, like statins and some diabetes drugs, available over the counter.  According to a CBS News report, “The new industry-backed proposal is driven … Read more